You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Correction: Tofacitinib for the treatment of moderately to severely active ulcerative colitis: a systematic review, network meta-analysis and economic evaluation

Article metrics

Article menu

See original article:

Download PDFPDF

XML
Correction
Correction: Tofacitinib for the treatment of moderately to severely active ulcerative colitis: a systematic review, network meta-analysis and economic evaluation

 

Online download statistics by month:

Online download statistics by month: February 2020 to September 2024

AbstractFullPdf
Feb 2020686012
Mar 202020019463
Apr 202011311219
May 2020605819
Jun 2020504918
Jul 202027279
Aug 2020262712
Sep 202047469
Oct 2020282611
Nov 2020262418
Dec 2020333412
Jan 202141398
Feb 2021151611
Mar 2021282512
Apr 202111106
May 202116169
Jun 202123235
Jul 202125258
Aug 2021202017
Sep 202122229
Oct 2021201722
Nov 2021201822
Dec 2021232310
Jan 202222258
Feb 202223248
Mar 202218188
Apr 2022232416
May 2022101013
Jun 202214149
Jul 202220206
Aug 2022202013
Sep 2022212221
Oct 2022272716
Nov 2022272312
Dec 202216166
Jan 202320206
Feb 2023131511
Mar 202318187
Apr 202315144
May 202315178
Jun 202316169
Jul 202313139
Aug 202313136
Sep 202321236
Oct 2023882
Nov 202320225
Dec 202310101
Jan 2024661
Feb 202417173
Mar 20248825
Apr 2024161610
May 202416166
Jun 202416155
Jul 202415156
Aug 202416114
Sep 2024982
Total14841455613